As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.

A study showed that base editing can repair mutations linked to a rare liver disease. The therapy restored liver and cellular ...

"If it ain't broke, don't fix it," goes the old adage, which Rice University professor James Chappell completely ignored in a recent Nature Communications publication. In the study, Chappell describes ...

Sharlin Health and Neurology Introduces New Stem Cell Therapy Program for Neurological Disorders in Ozark, MO Ozark, ...

New protocol generated glucose-responsive SC-islets from eight hPSC lines tested, demonstrating potential for autologous ...

Researchers at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed an improved method for ...

Researchers at Karolinska Institutet and KTH Royal Institute of Technology have developed an improved method for creating ...

They may look harmless, but they're certainly capable of turning your spreadsheets into traffic jams.

Researchers have built a synthetic-cell platform that can be chemically adjusted in real time, sidestepping a long-standing ...

A precision cancer strategy that selectively kills tumour cells while leaving healthy tissue intact may be within reach for the majority of colorectal cancer patients, according to new research ...

Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from ...

CiQUS researchers introduces an innovative chemical strategy to create biomimetic structures with greater efficiency. The design of more versatile and controllable synthetic cells could unlock new ...